Newron Pharmaceuticals S.p.A.

SIX:NWRN.SW

8 (CHF) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CHF.

2023202220212020201920182017201620152014201320122011201020092008200720062005
Operating Activities:
Net Income -16.2-17.493-14.901-20.998-20.207-15.035-5.282-15.237-22.816-10.095-7.713-2.497-6.437-21.673-24.351-16.356-11.089-16.401-14.919
Depreciation & Amortization 0.2010.2020.2090.2190.2060.1920.0480.0330.0710.0330.0390.0630.0880.1490.5240.2710.21300
Deferred Income Tax 00.402-2.514-2.688-1.968-5.103-3.141-2.309-2.923-0.1642.1230.6722.023.9743.262011.41900
Stock Based Compensation 0.1970.480.7621.4612.1262.1071.7392.2852.2511.230.8330.210.8420.0650.72100.62500
Change In Working Capital 1.636-0.8821.7521.227-0.1582.9961.4020.0240.672-1.066-3.6517.152-0.686-0.3131.144-2.369-1.29300
Accounts Receivables -1.307-0.8821.7521.227-0.1582.9911.402-0.0090.609-1.2670.71800000000
Inventory 000000.00500.0330.0630.201-0.0690.0130.15-0.0160.277-0.1350.82200
Accounts Payables 0000000000-0.71800000000
Other Working Capital 2.9432.191.9311.939-0.012-0.002-0.062-0.008-0.020-4.37.139-0.836-0.2970.867-2.234-2.11500
Other Non Cash Items 4.0266.1993.2475.191-1.975-1.111-6.311-6.6886.96-0.1-2.3170.225-0.769-1.329-4.356-1.478-13.7416.7710.59
Operating Cash Flow -10.14-11.092-11.445-15.588-21.976-15.954-8.404-19.583-12.862-9.998-10.6865.825-4.942-19.127-23.056-19.932-13.866-9.63-14.329
Investing Activities:
Investments In Property Plant And Equipment -0.011-0.018-0.02-0.034-0.051-0.034-0.024-0.069-0.06-0.016-0.076-0.011-0.001-0.007-0.064-0.36-0.339-0.052-0.101
Acquisitions Net -3.2570.299-8.440.5810.881000000.3019.971000-3.275000
Purchases Of Investments -0.981-3.04-1.698-2.215-3.0560-0.27500-6.9460000-1.6050000
Sales Maturities Of Investments 4.2382.74110.1381.6342.1753.00201.42.02600001.60200000.76
Other Investing Activites 3.257-0.2998.44-0.582-0.881-0.006-15.5630.1030.1190.1020.0010.0680.0660.0260.2252.022.5820.3010.097
Investing Cash Flow 3.246-0.3178.42-0.616-0.9322.962-15.8621.4342.085-6.860.22610.0280.0651.621-1.444-1.6152.2430.2490.756
Financing Activities:
Debt Repayment -0.192-0.186-0.169-0.135-0.163-0.154-0.364-0.362-0.36-0.359-0.357-0.35500000-0.0680
Common Stock Issued 000000.05123.80327.04829.09318.35608.59303.3516.55100.28766.63229.7
Common Stock Repurchased 0000000000000000000
Dividends Paid 0000000000000000000
Other Financing Activities -0.192-0.186157.517.50.076-1.479-1.6-0.701-0.8090-0.2152.157-0.447-0.629-0.343-0.2720.1360
Financing Cash Flow -0.192-0.18614.8317.36517.337-0.02721.9625.08628.03217.188-0.3578.0232.1572.9045.922-0.3430.01566.729.7
Other Information:
Effect Of Forex Changes On Cash 0000000000000000000
Net Change In Cash -7.086-11.59511.806-8.839-5.571-13.019-2.3066.93717.2550.33-10.81723.876-2.72-14.602-18.578-21.89-11.60857.31916.127
Cash At End Of Period 6.33813.42425.01913.21322.05227.62340.64242.94836.01118.75618.42629.2435.3678.08722.68941.26763.15774.76517.446